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Abstract
Purpose: To provide estimates of visual impairment in people with diabetes attending screening in a multi-ethnic
population in England (United Kingdom).
Methods: The Diabetic Retinopathy In Various Ethnic groups in UK (DRIVE UK) Study is a cross-sectional study on the ethnic
variations of the prevalence of DR and visual impairment in two multi-racial cohorts in the UK. People on the diabetes
register in West Yorkshire and South East London who were screened, treated or monitored between April 2008 to July
2009 (London) or August 2009 (West Yorkshire) were included in the study. Data on age, gender, ethnic group, visual acuity
and diabetic retinopathy were collected. Ethnic group was defined according to the 2011 census classification. The two
main ethnic minority groups represented here are Blacks (‘‘Black/African/Caribbean/Black British’’) and South Asians (‘‘Asians
originating from the Indian subcontinent’’). We examined the prevalence of visual impairment in the better eye using three
cut-off points (a) loss of vision sufficient for driving (approximately ,6/9) (b) visual impairment (,6/12) and (c) severe visual
impairment (,6/60), standardising the prevalence of visual impairment in the minority ethnic groups to the age-structure of
the white population.
Results: Data on visual acuity and were available on 50,331individuals 3.4% of people diagnosed with diabetes and
attending screening were visually impaired (95% confidence intervals (CI) 3.2% to 3.5%) and 0.39% severely visually
impaired (0.33% to 0.44%). Blacks and South Asians had a higher prevalence of visual impairment (directly age standardised
prevalence 4.6%, 95% CI 4.0% to 5.1% and 6.9%, 95% CI 5.8% to 8.0% respectively) compared to white people (3.3%, 95% CI
3.1% to 3.5%). Visual loss was also more prevalent with increasing age, type 1 diabetes and in people living in Yorkshire.
Conclusions: Visual impairment remains an important public health problem in people with diabetes, and is more prevalent
in the minority ethnic groups in the UK.
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Introduction
Visual impairment adds to the burden of several other
microvascular and macrovascular complications in people with
diabetes, threatens independence and compromises quality of life
[1]. Estimates of blindness in diabetes from the United Kingdom
(UK) are mainly based on audits of certifications of visual
impairments which are not population-based estimates [2–9].
Other sources of data on diabetes-related visual impairment in the
UK are derived from multipurpose health surveys aimed at a
specific population [10–12] or limited to the Caucasian population
[13–17].
The demographic composition of the UK is changing with a
rise in the ageing population and most of its metropolitan cities
now have an ethnically diverse composition. The prevalence of
diabetes is disproportionately higher in the non-Caucasian
ethnic groups [18]. It is clear that better glycaemic and blood
pressure control among people with diabetes has resulted in a
reduction of adverse outcomes of diabetes as observed in
previous studies conducted in the United States and the UK
[19], [20]. A recent report from the UK also suggested that
diabetic retinopathy (DR) is no longer the most common cause
of visual impairment in the working age-group [2]. It is
important to obtain current population-based data on low vision
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and severe visual impairment to understand the impact of these
changes on the healthcare burden in the UK.
These contemporary data will also provide baseline data to
assess the impact of diabetic retinopathy screening and forth-
coming new treatment options for diabetic macular oedema.
In 2010, the Association of Public Health Observatories
(AHPO) prevalence model estimated that there were approxi-
mately 3 million people aged 16 years or above with undiagnosed
and diagnosed diabetes in England [21]. The Quality and
Outcomes Framework (QOF) requires each general practice to
maintain a register for all people aged 17 years and over with
diabetes mellitus, which specifies whether the person has Type 1 or
Type 2 diabetes. These data are uploaded to the diabetic register
maintained by the DR screening programme. The UK has one of
the most developed and quality assured DR screening pro-
grammes in the world with a population coverage ranging from
80–95% [22]. People with sight threatening disease are referred to
hospital retinal services for timely management. It is therefore
feasible to obtain current epidemiological data from a large
nationally representative cohort on visual impairment in people
with diagnosed diabetes.
The aim of the Diabetic Retinopathy in Various Ethnic groups
in UK (DRIVE UK) is to provide a cross-sectional analysis of
visual acuity and diabetic retinopathy in people with diabetes
attending for screening in two ethnically diverse regions in the
UK.
Methods
Ethics Statement
The study adhered to the Declaration of Helsinki and was
approved by the Chair of the Research Ethics Committee of
King’s College Hospital NHS foundation trust and the London
School of Hygiene and Tropical Medicine. Written consent from
patients was not required for this project as only anonymized data
from the regional diabetes registers were analysed.
Study Methodology
The Diabetic Retinopathy in Various Ethnic groups in the UK
(DRIVE-UK) study is a cross-sectional analysis of two databases
containing data on a total of 57,144 people with diagnosed
diabetes in West Yorkshire (registered subjects with family
practices in Wakefield and North Kirklees) and South East
London (registered subjects with family practices in Lambeth,
Southwark and Lewisham). These regions provide populations
representative of the multiethnic inhabitants in the UK. The
minority ethnic groups constitute 7.6% of the population of the
UK with most settled in metropolitan cities [23]. The largest
minority groups can be categorised into Blacks (Black African,
Black Caribbean, any other Blacks) and South Asians (descent
from India, Pakistan and Bangladesh and SriLanka). South East
London has an ethnic mix of Blacks, South Asians, mixed and
other groups while South Asians are the predominant minority
ethnic group in West Yorkshire.
Data Collection
The majority (.95%) of the population in the UK are
registered with a family practice. Since the introduction of the
Quality and Outcomes Framework (QoF) all people diagnosed
with diabetes are placed on a register with their local family
practices so that systematic care can be provided. Data on age,
gender and type of diabetes and ethnicity are uploaded from
practice diabetes registers into a single collated list at the local DR
screening programmes. The digital photographic diabetic retinop-
athy screening programmes in the UK are well-established and
100% of people with diabetes are offered screening and the uptake
rates are at least 70%, with most screening programmes achieving
over 85% annually. It is therefore possible to analyse population-
based data on visual acuity on all people diagnosed with diabetes
who take up these services. Both programmes included in this
study provide a reasonably comprehensive coverage of diabetics in
the respective regions -95% in West Yorkshire and 81% in South
East London.
Individuals that require specialist input or treatment are
referred to specified hospital eye services for further management.
Those who are exempt from screening include those who are
excluded because they have no perception of light or suspended as
they are under the care of an ophthalmologist in secondary care
either due to sight threatening disease or because the fundus
cannot be assessed by digital photography. From the screening
databases in the two regions, data were collected on age, gender,
ethnicity, physician-reported type of diabetes, visual acuity and
grade of retinopathy. Similar data on people exempted from
screening were obtained from the certificates of visual impairment
and clinical records of hospital eye services. The cross-sectional
data were collected in August 2009 from West Yorkshire and
September 2009 in South East London and the data from the
latest episode of screening or eye clinic appointment within the last
15 months of the data collection date was used.
Ethnicity Data
Data on ethnicity were self ascertained using the 16 categories
recorded in the 2001 census (table 1) [23].
Visual Acuity Testing
The protocols for recording visual acuity in both screening
programmes were as recommended by the National Screening
Committee [24]. Presenting visual acuity for distance was
recorded for each eye before dilating the pupils for fundus
photography. This was measured with the participant wearing
their ‘‘walk-in’’ optical correction (i.e. spectacles or contact lenses)
using Early Treatment of Diabetic Retinopathy Study (ETDRS)
charts.24 If no letters were read at 2 metres, visual acuity was
assessed as counting fingers, hand movements, perception of light,
or no perception of light. The visual acuity of the better eye was
used for all analyses. Age-standardisation of the prevalence of
visual impairment in the minority ethnic groups was done based
on the age-structure of the white population.
Definition of Visual Impairment
We examined the prevalence of visual impairment in the better
eye using three cut-off points: (a) loss of vision sufficient for driving
(approximately ,6/9) (b) visual impairment (,6/12) and (c)
severe visual impairment (,6/60).
Screening and Grading of Diabetic Retinopathy
A mydriatic 2-field digital photography, one centred on the
optic disc and the other on the macula was carried out on all
diabetic people attending for screening. Trained graders carried
out a full disease grade on all image sets; a different grader then
independently assessed 10% of the no-disease sets and all-disease
image sets. If there was a difference of opinion about referral, the
images were arbitrated by an ophthalmologist. The grading of DR
was done according to the English Retinopathy Minimum grading
classification [25]. As some people with diabetes were followed up
in secondary care, the data on the grades of DR for these people
were obtained from hospital records.
Visual Impairment in People with Diabetes
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39608
Statistical Analyses
Data were analysed using STATA version 12 (StataCorp,
Texas, USA). Analyses were largely descriptive and included
calculating the percentage of people visually impaired according to
different definitions in different population subgroups with
associated 95% confidence intervals. We also did three logistic
regression models examining risk factors for visual impairment
(,6/9, ,6/12 and ,6/60) compared to those who are not in that
case-group. We included terms for age in 10-year age groups,
gender (male/female), location (London/Yorkshire), type of
diabetes (I/II) and ethnic group (Caucasian, African/Afro-
Caribbean and South Asian) and retinopathy grades (any DR,
sight threatening DR and maculopathy) in these models.
Results
The QOF data from general practitioners indicated that the
numbers of people with diagnosed diabetes within the specified
areas in West Yorkshire (North Kirklees and Wakefield) from June
2008-August 2009 and South East London (Lambeth, Lewisham
and Southwark) from July 2008-September 2009 were 20,878 and
36,266 respectively. Of these 18,558 (88.9%) and 31,773 (87.6%)
respectively had data on visual acuity and diabetic retinopathy
status during the data collection period in West Yorkshire and in
South East London and the data from the latest episode of
screening or eye clinic appointment within this time period was
used. In West Yorkshire, the numbers of people with no data
included those that were medically unfit for screening (268),
moved out of area (41), denied having diabetes (5) and had opted
out of the screening programme or screened elsewhere (82). A
further 1001 people had no ethnicity data, 11 were other types of
diabetes and no data was available from recent hospital records on
912 during this period. In South East London, the numbers of
people with no data included those that were medically unfit for
screening or institutionalised (235), moved out of area (142),
denied having diabetes (5), were under 12 years of age (10) and
had opted out of the screening programme or screened elsewhere
(244). A further 2710 had no ethnicity data and there were 1147
missing records from hospital eye services or general practices that
did not participate in uploading data to the screening pro-
grammes.
Table 2 shows the characteristics of the study population. The
mean age of the study population (n = 50,331) was 62.0 years with
59.7% being aged 60 years or older. There were similar numbers
of men and women. Overall, 34% of this study population were
composed of minority ethnic groups. The minority ethnic groups
in South East London and West Yorkshire comprised 47.1% and
12.6% of the total people with diabetes on the registers
respectively with South Asians predominating in West Yorkshire
and Blacks in South East London: Most people (93%) were
diagnosed with Type 2 diabetes. The prevalence of diagnosed
diabetes in this study is 4.1% with similar rates of diagnosed
diabetes between the three ethnic groups, suggesting that
undiagnosed diabetes and/or uptake of retinal screening remain
an issue especially in the minor ethnic groups in the UK.
Table 3 shows the distribution of vision in the study cohort by
various demographic factors.
Table 4 combines the data in the entire study population
according to various cut-points of visual acuity. Overall, 3787
(7.5%, 95% confidence intervals (CI) 7.3% to 7.8%) of the people
with diabetes attending screening were not eligible for driving
based on their presenting visual acuity and 1699 (3.4%, 3.2% to
3.5%) were visually impaired (,6/12) and 195 (0.4%, 0.33% to
0.44%) severely visually impaired (,6/60). The other cut-points
are provided for comparison purposes, for example, cut-points
(,=6/18 and ,=6/60) are the cut-points used by the National
Screening Committee. The table also shows the prevalence of
visual impairment by ethnic group, with the prevalence estimates
for the minority ethnic groups directly age-standardised to the age-
structure of the white population. There was a trend such that
people of black African/African-Caribbean origin, diagnosed with
diabetes and attending for screening, had a higher risk of visual
loss compared to their white European counterparts; people of
Table 1. Ethnic group classification: census classification.
White English/Welsh/Scottish/Northern Irish/Irish; Gypsy or Irish Traveller; Any other White background.
Mixed/multiple ethnic groups White and Black Caribbean; White and Black African; White and Asian; Any other Mixed/multiple ethnic background.
Asian/Asian British Indian; Pakistani; Bangladeshi; Chinese; Any other Asian background.
Black/African/Caribbean/Black British African; Caribbean; Any other Black/African/Caribbean background.
Other ethnic group Arab; Any other ethnic group
South Asian in this study is defined as Indians, Pakistanis, Bangladeshi and Srilankan.
doi:10.1371/journal.pone.0039608.t001
Table 2. Characteristics of the study population.
South East
London
N=31,773
West Yorkshire
N=18,558
Total
N=50,331
Mean age (SD) 61.1 (14.7) 63.6 (14.7) 62.0 (14.8)
N(%) N(%) N(%)
Age ,30 757 (2.4) 475 (2.6) 1232 (2.5)
Age 30–39 1674 (5.3) 716 (3.9) 2390 (4.8)
Age 40–49 4666 (14.7) 1801 (9.7) 6467 (12.9)
Age 50–59 6780 (21.3) 3419 (18.5) 10199 (20.3)
Age 60–69 7573 (23.8) 5024 (27.1) 12597 (25.0)
Age 70–79 7234 (22.8) 4771 (25.8) 12005 (23.9)
Age 80+ 3087 (9.7) 2324 (12.5) 5411 (10.8)
Male 16307 (51.3) 10318 (55.6) 26625 (52.9)
Diabetes Type I 2112 (6.7) 1211 (6.5) 3323 (6.6)
Diabetes Type II 29630 (93.4) 17332 (93.5) 46962 (93.4)
White 16815 (52.9) 16194 (87.4) 33009 (65.6)
Black 8227 (25.9) 149 (0.8) 8376 (16.7)
South Asian 1478 (4.7) 2040 (11.0) 3518 (7.0)
Mixed 2631 (8.3) 55 (0.3) 2686 (5.3)
Other 2622 (8.3) 91 (0.5) 2713 (5.4)
doi:10.1371/journal.pone.0039608.t002
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South Asian origin had a higher risk of visual impairment
compared to black African/Afro-Caribbean people on the register.
This trend was observed for each visual acuity cut-point, but since
there were relatively few cases of severe visual impairments, ethnic
differences in severity of visual impairment were not statistically
significant.
Logistic regression analyses (table 5) showed that the risk of
visual impairment in all 3 categories (visual impairment for driving
,6/9, visual impairment ,6/12 and severe visual impairment
,6/60) increased with increasing age but was not consistently
associated with gender. The risk of visual impairment in type 1
diabetes was twice that in type 2 diabetes. Minority ethnic groups
Table 3. Distribution of visual acuity by various demographic factors.
Vision in the
better eye
N(%) Total
South East
London
West
Yorkshire
Type I
diabetes
Type II
diabetes Men Women
White
European
African/Afro-
Caribbean
South
Asian
Total 50,330
(100)
31,773
(100)
18,557
(100)
3,323
(100)
46,961
(100)
26,624
(100)
23,691
(100)
33,009
(100)
8,376
(100)
3,518
(100)
.= 6/9 46,543
(92.5)
29,860
(94.0)
16,683
(89.9)
3,183
(95.8)
43,317
(92.2)
24,902 (93.5) 21,629
(91.3)
30,575
(92.6)
7,702
(92.0)
3,153
(89.6)
,6/9–6/12 2,088
(4.2)
1,036
(3.3)
1,052
(5.7)
75
(2.3)
2,012
(4.3)
957
(3.6)
1,129
(4.8)
1,345
(4.1)
364
(4.4)
196
(5.6)
,6/12–6/18 873
(1.7)
412
(1.3)
461
(2.5)
34
(1.0)
838
(1.8)
379
(1.4)
494
(2.1)
568
(1.7)
151
(1.8)
88
(2.5)
,6/18–6/60 631
(1.3)
342
(1.1)
289
(1.6)
26
(0.8)
604
(1.3)
285
(1.1)
345
(1.5)
401
(1.2)
114
(1.4)
65
(1.9)
,6/60 195
(0.4)
123
(0.4)
72
(0.4)
5
(0.2)
190
(0.4)
101
(0.4)
94
(0.4)
120
(0.4)
45
(0.5)
16
(0.5)
doi:10.1371/journal.pone.0039608.t003
Table 4. Prevalence of visual impairment in people with diabetes.
Visual impairment* Ethnic group Prevalence Age-standardised prevalence**
N % % 95 % CI
,6/9 (approximate cut-point for driving vision) All ethnic groups combined 3787 7.5 – –
White European 2434 7.4 7.4 7.1,7.6
African/Afro-Caribbean 674 8.0 9.7 9.0,10.4
South Asian 365 10.3 14.7 13.3,16.2
,6/12 (,= 6/18) (visual impairment) All ethnic groups combined 1699 3.4 – –
White European 1089 3.3 3.3 3.1,3.5
African/Afro-Caribbean 310 3.7 4.6 4.0,5.1
South Asian 169 4.7 6.9 5.8,8.0
,6/18 All ethnic groups combined 826 1.6 – –
White European 521 1.6 1.6 1.4,1.7
African/Afro-Caribbean 159 1.9 2.3 1.9,2.7
South Asian 81 2.3 3.1 2.4,3.9
,= 6/60 All ethnic groups combined 313 0.62 – –
White European 194 0.59 0.59 0.51,0.67
African/Afro-Caribbean 67 0.80 0.98 0.73,1.22
South Asian 27 0.77 1.22 0.71,1.74
,6/60 (severe visual impairment) All ethnic groups combined 195 0.39 – –
White European 120 0.36 0.36 0.30,0.43
African/Afro-Caribbean 45 0.54 0.64 0.44,0.83
South Asian 16 0.46 0.77 0.34,1.20
*Vision in the better eye. Study cut-points (,6/9, ,6/12 and ,6/60) given as well as cut-points for comparison purposes (,6/18 WHO visual impairment and ,= 6/60
NSC criteria).
**Standardised to the age-structure of the Caucasian population.
***In this dataset: ,6/12 was the same numerically as ,= 6/18 (NSC criteria).
White European n = 32,989 African/Afro-Caribbean n = 8375, South Asian n= 3510.
doi:10.1371/journal.pone.0039608.t004
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(both South Asians and Blacks) were twice as likely to be visually
impaired in all 3 categories of definitions compared to their white
counterparts. A regional variation in visual impairment was also
observed with the West Yorkshire cohort having more visual
impairment than South East London people.
Table 6 shows the association between retinopathy and visual
impairment in the right eye (similar results for left eye, data not
shown). Visual impairment increased with increasing signs of
retinopathy and maculopathy in the eye. Logistic regression
analyses, adjusting for age, sex, location and ethnic group, showed
that people with proliferative diabetic retinopathy in their right eye
had 13.8 times increased odds of having vision less than 6/9, 13.2
increased odds of having vision less than 6/12 and 11.4 increased
odds of having vision less than 6/60, in their right eye, compared
to people with no retinopathy in their right eye.
Discussion
Approximately 3.4% of people diagnosed with diabetes and
attending for screening were visually impaired (vision in the better
eye of ,6/12) and 0.39% were severely visually impaired. People
of Asian and African descent were twice at risk of visual
impairment in categories of driving vision, low vision and severe
visual impairment compared to white people.
This study highlights that even though people with diabetes
participate in screening of DR using digital fundus photography,
visual impairment remain a significant public health problem in
the UK. Current digital photographic retinal screening for DR
may not be sufficient to reduce the overall prevalence of visual
impairment in diabetes due to the low contribution of DR to visual
impairment. Uncorrected refractive error, cataract and glaucoma
are more common in people with diabetes than the non-diabetic
population and contribute more to visual impairment than
diabetic retinopathy [15], [26], [27]. Although people with
diabetes are offered free eye-sight test in UK, the spectacles are
often unaffordable. Studies from around the world also indicate
that the threshold to correct one’s refraction varies considerably
between ethnic groups. Furthermore, some of these ocular co-
morbidities such as cataract in South Asians and glaucoma in the
Afro-Caribbean population are more prevalent in certain ethnic
groups [27–29]. These factors may explain the ethnic differences
in visual impairment observed in this study.
Loss of vision is uncommon in studies on DR from Iceland. This
comparison with the Icelandic sample may not be ideal as the
population is relatively stable, exclusively Caucasian population
with few migrants and the provision for eyeglasses is covered. The
Icelandic population is also carefully screened for diabetes mellitus
and has been provided with regular screening for DR since 1983
Table 5. Logistic regression analysis for each of the visual impairment categories.
Odds ratio (95% CI)
Less than 6/9
(n =3787)
Less 6/12
(n =1699)
Less than 6/60
(n=195)
Age (per year age) 1.065 (1.062, 1.068) 1.073 (1.068,1.078) 1.082 (1.068,1.096)
Men 1 1 1
Women 1.27 (1.19,1.36) 1.25 (1.13,1.38) 0.90 (0.67,1.19)
South East London (DECS) 1 1 1
West Yorkshire (DRSS) 1.94 (1.79, 2.11) 1.74 (1.55,1.96) 1.02 (0.74, 1.43)
Type I diabetes 1 1 1
Type II diabetes 0.50 (0.41, 0.60) 0.44 (0.33, 0.57) 0.63 (0.26, 1.56)
White 1 1 1
Black 2.00 (1.80, 2.22) 1.98 (1.70, 2.29) 2.02 (1.38, 2.97)
Asians 2.21 (1.96, 2.50) 2.33 (1.96, 2.78) 2.00 (1.18, 3.41)
Other 1.39 (1.21, 1.59) 1.27 (1.04, 1.55) 0.98 (0.55, 1.75)
Vision in better eye; Adjusted for all other factors in the table.
doi:10.1371/journal.pone.0039608.t005
Table 6. Vision and diabetic retinopathy.
Retinopathy
in right eye No Retinopathy
Mild and moderate
non-proliferative
Retinopathy
Severe non-
proliferative
Retinopathy
Proliferative
diabetic
retinopathy
Diabetic
maculopathy
Vision in right eye N (%) N (%) N (%) N (%) N (%)
6/9 or better 30,755 (86.4) 10,129 (79.6) 459 (70.0) 431 (34.6) 1,708 (54.6)
,6/9–6/12 2,001 (5.6) 1181 (9.3) 87 (13.2) 182 (14.6) 480 (15.4)
,6/12–6/18 1,259 (3.5) 690 (5.4) 42 (6.4) 235 (18.9) 355 (11.4)
,6/18–6/60 1,080 (3.0) 554 (4.4) 59 (9.0) 233 (18.7) 402 (12.9)
,6/60 494 (1.4) 179 (1.4) 13 (2.0) 166 (13.3) 179 (5.7)
35,589 (100) 12,733 (100) 660 (100) 1,247 (100) 3,124 (100)
doi:10.1371/journal.pone.0039608.t006
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[30], [31]. It is still too early for the national systematic screening
programme for DR in UK to produce a positive impact on the
prevalence of visual impairment. Only time will tell if such findings
could be translated to a multiracial and mobile population.
The analyses of severity of DR between ethnic groups in this
study showed that the minority groups are also twice as likely to
have sight threatening DR is also twice in compared to the
Caucasian counterpart [32]. People with proliferative DR and
persistent maculopathy despite laser treatment are especially
vulnerable to visual impairment. These observations are
consistent with the findings of the UKADS study on South
Asians that showed that the risk of sight threatening retinopathy
is significantly higher than Caucasians and that this disparity
could partly be explained by differential susceptibility to
systemic risk factors [33]. Previous studies evaluating ethnic
differences in certifications of visual impairment also showed
similar results with the proportion of South Asians who are
registered blind due to DR being three times that of the
Caucasians in the UK [6], [8]. So, it is likely that DR may also
contribute to the higher prevalence of visual impairment in this
minority population. There is very limited data on visual
impairment in the Blacks with diabetes in the UK.
The other risk factors in minor ethnic groups include an earlier
age of onset of diabetes and poorer health care utilization rates
[34]. These findings are of concern, as subjects who are at highest
risk seem to have poorer outcomes. Previous studies on education
levels and socio-economic status have shown that people with low
income and those with lower levels of education are at higher risk
of visual impairment, cataract and PDR [35]. The effect of race on
ocular diseases was highlighted as early as 1990 in the United
States in the Baltimore Eye Survey that showed that people of
African descent had, on average, a twofold greater prevalence of
blindness and visual impairment compared to Caucasians [36].
This effect of race was reduced after adjustment of the socio-
economic factors. Socio-economic deprivation is likely to play a
role in outcome and may be a limiting factor in this study. The
rates of visual impairment in high income countries are going
down and this is not mirrored in the UK as yet. Perhaps the stable
rates in the UK may be in part attributable to the continued influx
of immigrants with diabetes which, in turn negate the benefits
made to reduce the risk of DR among long standing residents
whose diabetes has been carefully managed for some time. So,
further research into individual level data focussing on this aspect
in the UK is warranted.
This study also confirmed that increasing age is a risk factor
for visual impairment in diabetes. Although DR is the
commonest cause of visual impairment in the working age-
group, relative to other causes, people aged 65 years and older
with diabetes are three times more likely to be visually impaired
(in all 3 categories- driving vision, low vision and severely
visually impaired) compared to those between 16–64 years. It
may be postulated that these figures may only reflect the
increasing prevalence of diabetes in the older people who
mainly suffer from other causes of visual impairment especially
cataract and age related macular degeneration. However, Bunce
et al observed that the rates of registration (both low vision and
blindness) due to DR in the elderly have increased significantly
in the last two decades [3]. Although this rise is often attributed
to increased public, professional and political awareness of
certifications and support provided as part of the VISION 2020
strategy, this study highlights the fact that visual impairment is
definitely a significant public health issue in the older
population with diabetes.
Visual impairment also occurs more frequently in people with
type 1 diabetes compared to type 2 diabetes. Screening and timely
management of DR has been shown to reduce the risk of visual
impairment in people with type 1 diabetes [37]. A similar
reduction in type 2 diabetes is more difficult to achieve unless
diabetes is diagnosed early and appropriate interventions are given
promptly [38].
We have focused on presenting vision–that is, visual acuity as
used in everyday life by the people taking part in DR screening.
This measure of visual impairment is the most relevant for public
health purposes [11]. Despite that our prevalence may be an
underestimate of visual impairment in people with diabetes
because the study did not include non-attenders to the screening
programmes and associated eye clinics. Our previous study on the
South East London cohort indicated that screening uptake rates
were particularly poor among the young adults aged 18–34 years
and those aged 85 years or greater [39].
Another limitation of our study is that approximately 30% of
the non-participants were those referred to hospital eye services for
referable DR or unclassifiable retinopathy using digital photogra-
phy due to ungradable images. So it is likely that the actual
prevalence of visual impairment may again be underestimated as
there is variability in assessing DR severity grade between
screening programmes and secondary care. However, the results
of our study compare well with other studies that examined
subjects from the local diabetic retinopathy screening programmes
in predominantly Caucasian-inhabited regions in the UK. The
Liverpool Eye study in 1999 observed that 3.4% had visual acuity
of #6/24 and 0.8% had visual acuity of #6/60 [40]. Prasad et al
noted that the prevalence of low vision and blindness as per WHO
classification in Wirral were 2% and 0.75% in 2000 [14] and in
Gloucestershire, Scanlon et al reported these to be 2.9% and
0.45% respectively in 2008 [15]. It is useful to note that whatever
be the source of data collection (survey of DR screening database
or register of certifications of visual impairment), the prevalence of
visual impairment in people with diabetes has been stable in the
last decade [3], [5–8], [14], [15].
In summary, this study highlights the ethnic –specific prevalence
of visual impairment in the UK. The ethnic differences may be
due to patient level characteristics such as genetic differences;
differences in control of risk factors of diabetes; differences in
knowledge of complications of diabetes; or service level charac-
teristics including access to care and treatment outcomes or
probably a combination of these factors.
With the increasing population, the demographic right shift of
the population and the emerging racial-mix in most cities in the
UK, [18], [23] it is important to identify the causes of visual
impairment in people with diabetes before any strategic recom-
mendations can be made in relation to resource allocation.
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